Fatores relacionados à adesão das drogarias e farmácias de Tatuí-SP no projeto Farmácias Notificadoras

• Autor(a) principal: Barreto, Gabriela Gueri
• Data de Publicação: 2008
• Outros Autores: Simões, M. J. S. [UNESP]
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://serv-bib.fcfar.unesp.br/seer/index.php/Cien_Farm/article/view/435; http://hdl.handle.net/11449/70614
• topic: Adverse reactions; Notifying pharmacies; Pharmaceutical attention; Pharmacies; Pharmacovigilance; attitude to health; Brazil; drug surveillance program; factorial analysis; health care access; health care organization; health service; observational study; pharmacist; pharmacist attitude; pharmacy; professional knowledge

Pharmacovigilance is accomplished by voluntary notification of suspected adverse reactions, medication errors, and deviations from quality, by users and health professionals, through the filling in of forms that are sent to a data bank. To broaden the sources of notifications, the National Health Surveillance Agency (ANVISA), in partnership with the Regional Pharmacy Council (CRF) and Center for Health Surveillance (CVS) of each state, introduced the scheme of Notifying Pharmacies. The present study was aimed at determining the factors influencing the decision of drugstores and private pharmacies in Tatuí/SP in 2007, to join this project A descriptive, observational survey of knowledge, attitude and practice (KAP) was applied to volunteer pharmacists in the town. The results showed that the professionals are awave of pharmacovigilance, (95.24%) and have attitude (95.24%). However, practice is limited (6.0%). Based on this information we concluded that the low support of the project was due to lack of time, interest and no information about the benefits to society of such activity and a lack of support from the pharmacists' organizations. This situation is expected to change with the current introduction of a professional profile, the fusion of professional bodies and the promotion of social awareness on pharmacovigilance.